Skip to main content

Find Clinical Trials

Home
Conditions
Myelodysplastic Syndrome-Refractory Anemia With Excess Blasts

Clinical trial condition

Myelodysplastic Syndrome-Refractory Anemia With Excess Blasts

Explore clinical trials studying Myelodysplastic Syndrome-Refractory Anemia With Excess Blasts. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Myelodysplastic Syndrome-Refractory Anemia With Excess Blasts trial results

Completed

Vaccination With GM-K562 Cells in Patients With Advanced Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) After Allogeneic Hematopoetic Stem Cell Transplantation

NCT00809250

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +14 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details